PlugIN: PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients (clinicaltrials.gov) - Sep 19, 2026 - P2 | N=60 | Active, not recruiting | Sponsor: Grupo Español Multidisciplinar de Melanoma | Recruiting ➔ Active, not recruiting
Enrollment closed • Melanoma • Oncology • Solid Tumor • BRAF • PD-L1
|